Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00063193 · ClinicalTrials.gov registry record · Phase 2

National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial

A Phase 2 study of Parkinson's Disease, sponsored by University of Rochester.

Completed
Registry status
Phase 2
Development phase
195
Enrollment target
1
Study location

NCT00063193 is a Phase 2 study of Parkinson's Disease that has completed, run by University of Rochester. The registered enrollment target is 195 participants, below the 641-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00063193, a Phase 2 study of Parkinson's Disease, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
Phase 2
Development phase
195 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.

Conditions Studied

Parkinson's Disease

Interventions

  • DRUG minocycline
  • DRUG creatine

Study Locations (1)

New York

  • University of Rochester Medical Center - Rochester

Trial Details

FieldValue
Enrollment Target 195 participants
Start Date 2003-05
Est. Completion 2005-07
Phase Phase 2

Sponsor

University of Rochester

636 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00063193

The ClinicalTrials.gov registry entry for NCT00063193 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 641-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (70% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which minocycline is the first listed.

NCT00063193 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00063193 about?

NCT00063193 is a clinical study titled "National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial". The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.

What is the current status of trial NCT00063193?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 195 participants. The study started on 2003-05. Estimated completion is 2005-07.

What conditions does trial NCT00063193 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT00063193?

The interventions under investigation include: minocycline (DRUG), creatine (DRUG).

Who is sponsoring clinical trial NCT00063193?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00063193 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.